Wealth Enhancement Advisory Services’s iShares US Medical Devices ETF IHI Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.47M	Sell	184,550 -3,643	-2%	-$185K	0.02%	691
2026 Q1	$10M	Sell	188,193 -104,538	-36%	-$6.14M	0.02%	582
2025 Q4	$18.9M	Buy	292,731 +1,388	+0.5%	+$85.7K	0.03%	494
2025 Q3	$17.5M	Sell	291,343 -934	-0.3%	-$57.1K	0.03%	488
2025 Q2	$18.2M	Buy	292,277 +24,911	+9%	+$1.5M	0.03%	447
2025 Q1	$16.1M	Buy	267,366 +45,423	+20%	+$2.82M	0.03%	456
2024 Q4	$13M	Buy	221,943 +6,781	+3%	+$403K	0.02%	492
2024 Q3	$12.7M	Sell	215,162 -4,238	-2%	-$242K	0.03%	454
2024 Q2	$12.3M	Sell	219,400 -3,225	-1%	-$181K	0.03%	431
2024 Q1	$13M	Buy	222,625 +1,103	+0.5%	+$62.3K	0.03%	405
2023 Q4	$12M	Sell	221,522 -554	-0.2%	-$27.1K	0.03%	392
2023 Q3	$10.8M	Buy	+222,076	New	+$11.8M	0.04%	389

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wealth Enhancement Advisory Services's IHI Position: Q2 2026 in Review

Wealth Enhancement Advisory Services reduced its iShares US Medical Devices ETF (IHI) stake by 1.9% in Q2 2026, selling an estimated $185K and leaving 184,550 shares worth $9.47M. The position accounts for 0.02% of the portfolio, ranked #691.

Wealth Enhancement Advisory Services first reported a position in IHI in Q3 2023 and has held it in 12 quarters since. The position peaked at $18.9M in Q4 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Wealth Enhancement Advisory Services held 184,550 shares of iShares US Medical Devices ETF worth $9.47M as of Q2 2026.
Wealth Enhancement Advisory Services sold 3,643 iShares US Medical Devices ETF shares in Q2 2026, an estimated $185K.
iShares US Medical Devices ETF made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #691 holding.
Wealth Enhancement Advisory Services first reported a position in iShares US Medical Devices ETF in Q3 2023 and has held it in 12 quarters since.
Wealth Enhancement Advisory Services's iShares US Medical Devices ETF position peaked at $18.9M in Q4 2025.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.